Evidence map›Paper›PMID 23840749›Full record

ArticlePloS one2013

MOR is not enough: identification of novel mu-opioid receptor interacting proteins using traditional and modified membrane yeast two-hybrid screens.

Jessica Petko, Stephanie Justice-Bitner, Jay Jin, Victoria Wong, Saranya Kittanakom, Thomas N Ferraro, Igor Stagljar, Robert Levenson

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. In vivo mapping of a GPCR interactome using knockin mice.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  4. Article
  5. Article
  6. Molecular Pharmacology of δ-Opioid Receptors.Pharmacological reviews · 2016
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Jessica PetkoDepartment of Pharmacology, Penn State College of Medicine, Hershey, Pennsylvania, United States of America.
Stephanie Justice-Bitner
Jay Jin
Victoria Wong
Saranya Kittanakom
Thomas N Ferraro
Igor Stagljar
Robert Levenson
Penn State Milton S. Hershey Medical Center · USUniversity of Toronto · CAUniversity of Pennsylvania · US

Funding

Mu Opioid Receptor in AddictionP20DA025995 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI BERRETTINI, WADE H · 2008 to 2011
$3.4M
CIHRNIDA NIH HHS DA025995NIDA NIH HHS P20 DA025995
6 · The paper itself

Abstract

The mu-opioid receptor (MOR) is the G-protein coupled receptor primarily responsible for mediating the analgesic and rewarding properties of opioid agonist drugs such as morphine, fentanyl, and heroin. We have utilized a combination of traditional and modified membrane yeast two-hybrid screening methods to identify a cohort of novel MOR interacting proteins (MORIPs). The interaction between the MOR and a subset of MORIPs was validated in pulldown, co-immunoprecipitation, and co-localization studies using HEK293 cells stably expressing the MOR as well as rodent brain. Additionally, a subset of MORIPs was found capable of interaction with the delta and kappa opioid receptors, suggesting that they may represent general opioid receptor interacting proteins (ORIPS). Expression of several MORIPs was altered in specific mouse brain regions after chronic treatment with morphine, suggesting that these proteins may play a role in response to opioid agonist drugs. Based on the known function of these newly identified MORIPs, the interactions forming the MOR signalplex are hypothesized to be important for MOR signaling and intracellular trafficking. Understanding the molecular complexity of MOR/MORIP interactions provides a conceptual framework for defining the cellular mechanisms of MOR signaling in brain and may be critical for determining the physiological basis of opioid tolerance and addiction.

Indexed as

Analgesics, OpioidAnimalsBrainCell LineFemaleHEK293 CellsHumansImmunoprecipitationMiceMice, Inbred C57BLMorphineNuclear ProteinsReceptors, Opioid, deltaReceptors, Opioid, kappaReceptors, Opioid, muSeven in Absentia ProteinsAnalgesics, OpioidMorphineNuclear ProteinsReceptors, Opioid, deltaReceptors, Opioid, kappaReceptors, Opioid, muSeven in Absentia ProteinsUbiquitin-Protein Ligases

Identifiers

PMID23840749
PMCPMC3695902
OpenAlexW2011287700

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.